Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition. | Oncogene | 2019 | 31285551 | PubTator, text mining | PubMed |
| Successful Outcome of a Case of Acute Myeloid Leukemia with t(8;21)/AML-ETO Following Langerhans Cell Histiocytosis | Turk J Haematol | 2019 | 31284703 | PubTator, text mining | PubMed |
| ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. | Nat Med | 2019 | 31263281 | PubTator, text mining | PubMed |
| Neurodevelopmental Aspects of RASopathies. | Mol Cells | 2019 | 31250618 | PubTator, text mining | PubMed |
| Molecular targeted therapy of BRAF-mutant colorectal cancer. | Ther Adv Med Oncol | 2019 | 31244912 | PubTator, text mining | PubMed |
| Development of Allosteric BRAF Peptide Inhibitors Targeting the Dimer Interface of BRAF. | ACS Chem Biol | 2019 | 31243962 | PubTator, text mining | PubMed |
| Parallel-Reaction-Monitoring-Based Proteome-Wide Profiling of Differential Kinase Protein Expression during Prostate Cancer Metastasis in Vitro. | Anal Chem | 2019 | 31241916 | PubTator, text mining | PubMed |
| CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | Cell Death Discov | 2019 | 31240132 | PubTator, text mining | PubMed |
| The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas. | Front Endocrinol (Lausanne) | 2019 | 31231308 | PubTator, text mining | PubMed |
| Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes. | J Thorac Oncol | 2019 | 31228622 | PubTator, text mining | PubMed |
| Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors. | JCO Precis Oncol | 2019 | 31218271 | PubTator, text mining | PubMed |
| SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics. | Proc Natl Acad Sci U S A | 2019 | 31213532 | PubTator, text mining | PubMed |
| MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. | J Clin Med | 2019 | 31207946 | PubTator, text mining | PubMed |
| Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma. | Acad Pathol | 2019 | 31206012 | PubTator, text mining | PubMed |
| Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer. | Int J Mol Sci | 2019 | 31200510 | PubTator, text mining | PubMed |
| MAP3K kinases and kidney injury. | Nefrologia (Engl Ed) | 2019 | 31196660 | PubTator, text mining | PubMed |
| Targeting ERK beyond the boundaries of the kinase active site in melanoma. | Mol Carcinog | 2019 | 31190430 | PubTator, text mining | PubMed |
| ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells. | J Oncol | 2019 | 31186633 | PubTator, text mining | PubMed |
| Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report. | BMC Cancer | 2019 | 31185985 | PubTator, text mining | PubMed |
| Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. | NMR Biomed | 2019 | 31184789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=56